HealthEquity (HQY) earnings
In the quarter ended July 2026, HealthEquity had revenue of $351M, up 7.6% on a year earlier, and diluted EPS of 0.78.
On August 27, 2026 it reported EPS of 1.04 against an estimate of 0.99 (beat).
The next report is expected on Wednesday, December 2, 2026, with EPS expected around 0.96.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Wed Dec 2, 2026 | — | 0.96 | — |
| Last | Thu Aug 27, 2026 | — | 0.99 | 1.04 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from HealthEquity's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | $351M | +7.6% | 0.78 | +14.7% | 28.1% | 2026-08-27 |
| Apr 30, 2026 | $355M | +7.2% | 0.82 | +34.4% | 29.0% | 2026-05-28 |
| Jan 31, 2026 | $335M | +7.3% | — | — | 21.2% | 2026-03-17 |
| Oct 31, 2025 | $322M | +7.2% | 0.59 | +883.3% | 24.4% | 2025-12-03 |
| Jul 31, 2025 | $326M | +8.6% | 0.68 | +70.0% | 27.5% | 2025-09-02 |
| Apr 30, 2025 | $331M | +15.0% | 0.61 | +84.8% | 25.1% | 2025-06-03 |
| Jan 31, 2025 | $312M | +18.8% | — | — | 13.5% | 2025-03-18 |
| Oct 31, 2024 | $300M | +20.5% | 0.06 | -64.7% | 6.5% | 2024-12-09 |
| Jul 31, 2024 | $300M | +23.1% | 0.40 | +233.3% | 19.6% | 2024-09-03 |
| Apr 30, 2024 | $288M | +17.7% | 0.33 | +560.0% | 14.5% | 2024-06-03 |
| Jan 31, 2024 | $262M | +12.2% | — | — | 14.8% | 2024-03-22 |
| Oct 31, 2023 | $249M | +15.3% | 0.17 | — | 12.4% | 2023-12-05 |
Questions
When does HealthEquity report earnings?
HealthEquity's next earnings report is expected on December 2, 2026.
How did HealthEquity do last quarter?
In the quarter ended July 2026, HealthEquity had revenue of $351M, up 7.6% on a year earlier, and diluted EPS of 0.78.
From HealthEquity's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.